SEC Form 4 · accession 0001140361-18-012141
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ralf Kuriyel
Officer — Senior VP, R&D
Period of report
Mar 1, 2018
Accepted (ET)
Mar 5, 2018 · 10:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2018 | A | 6,643 | $0.00 | A | 12,605 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $33.87 | Mar 1, 2018 | A | 12,850 | A | — | Mar 1, 2028 | Common Stock | 12,850 | 12,850 | D |
Explanation of responses
- F1Mr. Kuriyel was awarded 6,643 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- F2The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.